Cryopyrin-Associated Periodic Syndrome (CAPS) Caused by c.943A>G Variant of NLRP3 Gene: Clinical Case

Background. Cryopyrin-associated periodic syndromes is a group of rare congenital autoinflammatory diseases such as familial cold autoinflammatory syndrome, Muckle-Wells syndrome and chronic infantile neurological cutaneous articular syndrome. These syndromes are considered as clinical variants of o...

Full description

Bibliographic Details
Published in:	Вопросы современной педиатрии
Main Authors:	Ivan A. Kriulin, E. I. Alexeeva, Tatyana M. Dvoryakovskaya, Bella I. Bursagova, Kirill V. Savostyanov, Natalya V. Zhurkova, Alexander A. Pushkov, Anatoli V. Anikin, Artem M. Nesterov
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2019-11-01
Subjects:	children autoinflammatory syndromes cryopyrin-associated periodic syndrome tnfrsf1a gene nlrp3 gene il-1 beta inhibitor canakinumab
Online Access:	https://vsp.spr-journal.ru/jour/article/view/2202

Similar Items

DIAGNOSIS AND TREATMENT OF PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME
by: A. L. Kozlova, et al.
Published: (2015-04-01)

EXPERIENCE IN APPLICATION OF CANAKINUMAB IN PATIENTS WITH CRYOPYRIN-ASSOCIATED SYNDROME (SYNDROME CINCA/NOMID)
by: T. V. Sleptsova, et al.
Published: (2014-05-01)

Treating TRAPS Syndrome with a Previously Undescribed TNF α Gene Receptor Mutation Successfully with Canakinumab
by: T. V. Sleptsova, et al.
Published: (2016-11-01)

Cryopyrin-associated periodic syndrome Muckle — Wells: A Case Report
by: N. V. Shakhova, et al.
Published: (2023-07-01)

The interleukin 1 inhibitor canakinumab in the treatment of cryopyrin-associated periodic syndromes (CAPS): clinical experience
by: Svetlana Olegovna Salugina, et al.
Published: (2014-12-01)

Current approaches to diagnosis, treatment, and monitoring in patients with cryopyrin-associated periodic syndromes (CAPS)
by: S. O. Salugina, et al.
Published: (2016-06-01)

Effectiveness and safety of canakinumab in cryopyrin-associated periodic syndrome: a retrospective study in China
by: Xiaona Zhu, et al.
Published: (2024-09-01)

EXPERIENCE OF THE SUCCESSFUL CANAKINUMAB TREATMENT OF A PATIENT WITH UNDIFFERENTIATED AUTOINFLAMMATORY SYNDROME
by: Tatyana V. Sleptsova, et al.
Published: (2016-11-01)

Experience of the successful treatment with canakinumab of a patient with NLPC4-associated autoinflammatory syndrome with enterocolitis
by: T. V. Sleptsova, et al.
Published: (2016-06-01)

CRYOPYRIN ASSOCIATED PERIODIC SYNDROME
by: M. Gattorno
Published: (2013-02-01)

Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study
by: Ekaterina Alexeeva, et al.
Published: (2023-11-01)

Use of anakinra in cryopyrin-associated periodic syndromes: case report and review of literature
by: Marta Salas Sánchez, et al.
Published: (2025-06-01)

Similarities and differences in autoinflammatory diseases with urticarial rash, cryopyrin-associated periodic syndrome and Schnitzler syndrome
by: Tomoko Matsuda, et al.
Published: (2023-07-01)

A familial case of Muckle-Wells syndrome in a Russian population: The first successes of therapy with the interleukin 1 inhibitor canakinumab
by: S. O. Salugina, et al.
Published: (2015-03-01)

Case Report: Efficacy, safety, and favorable long-term outcome of early treatment with IL-1 inhibitors in a patient with chronic infantile neurological cutaneous articular (CINCA) syndrome caused by NLRP3 mosaicism
by: Giorgio Costagliola, et al.
Published: (2024-04-01)

Adult onset cryopyrin-associated periodic syndrome due to germline missense mutation in NLRP3 in a previously healthy middle-aged woman
by: Sung Ik Cho, et al.
Published: (2025-08-01)

The genetic and clinical characteristics and effects of Canakinumab on cryopyrin-associated periodic syndrome: a large pediatric cohort study from China
by: Zhou Shu, et al.
Published: (2023-09-01)

Results of molecular genetic screening of mutations in the NLRP3, TNFRSF1A, and MVK genes in patients with autoinflammatory diseases and systemic juvenile arthritis
by: S. O. Salugina, et al.
Published: (2017-09-01)

Cryopyrin-Associated Periodic Syndromes (CAPS): Pathogenesis, Clinical Manifestations, and IL-1-Targeted Therapeutic Strategies
by: Joanna Nadaj, et al.
Published: (2025-07-01)

How to identify a patient with autoinflammatory syndrome: Clinical and diagnostic algorithms
by: Mikhail Mikhailovich Kostik, et al.
Published: (2013-10-01)

CINCA/NOMID is a rare autoinflammatory syndrome in rheumatological practice. Experience of diagnosis, management and therapy with interleukin-1 inhibitors
by: S. O. Salugina, et al.
Published: (2024-04-01)

Novel deleterious sequence change in the NLRP12 gene in a child with autoinflammatory syndrome, joint hypermobility and cutis laxa from India.
by: Kanjaksha Ghosh, et al.
Published: (2019-02-01)

Schnitzler syndrome refractory to anakinra: successful treatment with canakinumab
by: Angel Luis Salcedo-Mingoarranz, et al.
Published: (2023-12-01)

CASE OF USING THE INHIBITOR OF INTERLEUKIN 1 CANACINUMAB IN PATIENTS WITH AUTO INFLAMMATORY DISEASES
by: S. O. Salugina, et al.
Published: (2015-04-01)

Bilateral Optic Disc Swelling as a Plausible Common Ocular Sign of Autoinflammatory Diseases: Report of Three Patients with Blau Syndrome or Cryopyrin-Associated Periodic Syndrome
by: Toshihiko Matsuo, et al.
Published: (2021-12-01)

Autoinflammatory Syndromes in the Practice of Pediatrician
by: S.N. Nedelskaya, et al.
Published: (2014-08-01)

Use of Anakinra in Patients with Cryopyrin-Associated Periodic Syndromes and Other Autoinflammatory Diseases
by: Mikhail M. Kostik
Published: (2016-12-01)

NLRP3 inflammasome and hearing loss: from mechanisms to therapies
by: Silvia Murillo-Cuesta, et al.
Published: (2025-10-01)

Investigator-initiated, multi-center, single-arm, open-label study of the effectiveness of canakinumab in Japanese patients with Schnitzler syndrome
by: Naotomo Kambe, et al.
Published: (2025-04-01)

Comprehensive Clinical Analysis of Rilonacept in the Treatment of Cryopyrin-Associated Periodic Syndromes: A Systematic Review
by: Zhang T, et al.
Published: (2025-05-01)

Schnitzler Syndrome: An Under-Recognised Cause of Pyrexia of Unknown Origin
by: Dennis Tin Ho Chan, et al.
Published: (2025-07-01)

NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies
by: Chiara Moltrasio, et al.
Published: (2022-10-01)

From Urticaria to Correct Diagnosis: A Case Report of Cryopyrin-Associated Periodic Syndromes
by: Wang X, et al.
Published: (2025-04-01)

Clinical and Laboratory Parameters of Autoinflammatory Disorders in Single Tertiary Care Center
by: Roya Sherkat, et al.
Published: (2022-04-01)

Is Canakinumab Safe During Pregnancy? New Insights from Three Cases in Slovakia
by: Branislav Slenker, et al.
Published: (2025-04-01)

Autoinflammatory gene mutations associated with eosinophilia and asthma
by: Bashayr M. Alotaibi, et al.
Published: (2023-08-01)

Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry
by: Prasad T. Oommen, et al.
Published: (2024-12-01)

The Role of Interleukin-1 Beta C-511T as a Modifier Polymorphism in Cryopyrin-associated Periodic Syndromes
by: Berk Özyılmaz, et al.
Published: (2019-09-01)

Genetic variations in NLRP3 and NLRP12 genes in adult-onset patients with autoinflammatory diseases: a comparative study
by: Mark Yun, et al.
Published: (2024-01-01)

The autoinflammatory diseases
by: Silvia Federici, et al.
Published: (2012-06-01)